Anti-PRPF31 antibody [EPR14587],Abcam,AB188577

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Rat, Human

Application

Flow Cyt (Intra), ICC/IF, WB

Platform ID

BAB321067636

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-PRPF31 antibody [EPR14587]
Cat. No.AB188577
HostRabbit
IsotypeIgG
ReactivityRat, Human
ApplicationFlow Cyt (Intra), ICC/IF, WB
ClonalityMonoclonal
Clone NumberEPR14587
Concentration1.323 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Involved in pre-mRNA splicing as component of the spliceosome (PubMed : 11867543, PubMed : 20118938, PubMed : 28781166). Required for the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed : 11867543). See full target information PRPF31

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.